Vaccine compositions for human papillomavirus
US6551597B1 · kind B1 · utility
8Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2000 |
| Grant date | Apr 22, 2003 |
| Priority date | — |
| Expiry date | Mar 8, 2020 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Large quantities of soluble multimers of human papillomavirus L1 proteins can be produced in bacterial expression systems and used as therapeutic and diagnostic tools. L1 multimers can be used in immunogenic vaccine compositions, as diagnostic reagents, and as tools for mapping cell surface receptor interactions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.